These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24238791)

  • 61. Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients.
    Pereira-Gómez M; Bou JV; Andreu I; Sanjuán R
    PLoS One; 2016; 11(9):e0163363. PubMed ID: 27649318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
    Freiman JS; McCaughan GW
    J Gastroenterol Hepatol; 2000 Mar; 15(3):227-9. PubMed ID: 10764020
    [No Abstract]   [Full Text] [Related]  

  • 63. [New treatment options in chronic hepatitis B].
    Mondelli M
    Infez Med; 2008 Mar; 16(1):5-14. PubMed ID: 18367877
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.
    Haché C; Villeneuve JP
    Expert Opin Pharmacother; 2006 Sep; 7(13):1835-43. PubMed ID: 16925509
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current therapies for chronic hepatitis B virus infection.
    Karayiannis P
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):745-60. PubMed ID: 15482237
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical and virologic characteristics and treatment for chronic hepatitis B: relation with HBV genotypes].
    Orito E; Mizokami M
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jun; 102(6):665-72. PubMed ID: 15981622
    [No Abstract]   [Full Text] [Related]  

  • 67. Therapy of chronic hepatitis B: current challenges and opportunities.
    Liaw YF
    J Viral Hepat; 2002 Nov; 9(6):393-9. PubMed ID: 12431200
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?
    Shaw T; Bowden S; Locarnini S
    Gastroenterology; 2004 Jan; 126(1):343-7. PubMed ID: 14699512
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacoeconomics of entecavir treatment for chronic hepatitis B.
    You JH; Chan FW
    Expert Opin Pharmacother; 2008 Oct; 9(15):2673-81. PubMed ID: 18803453
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil.
    Costa AM; L 'italien G; Nita ME; Araujo ES
    Braz J Infect Dis; 2008 Oct; 12(5):368-73. PubMed ID: 19219274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The management of chronic viral hepatitis: a Canadian consensus conference 2004.
    Sherman M; Bain V; Villeneuve JP; Myers RP; Cooper C; Martin S; Lowe C
    Can J Gastroenterol; 2004 Dec; 18(12):715-28. PubMed ID: 15605136
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Advances in treatment of chronic hepatitis B].
    Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):95-7. PubMed ID: 15812879
    [No Abstract]   [Full Text] [Related]  

  • 73. Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis.
    Henriquez-Camacho C; Hijas-Gomez AI; Risco Risco C; Ruiz Lapuente MA; Escudero-Sanchez R; Cuerda VM
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005918
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiviral resistance and hepatitis B therapy.
    Ghany MG; Doo EC
    Hepatology; 2009 May; 49(5 Suppl):S174-84. PubMed ID: 19399794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiviral therapy and resistance with hepatitis B virus infection.
    Tillmann HL
    World J Gastroenterol; 2007 Jan; 13(1):125-40. PubMed ID: 17206760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a systematic review and meta-analysis.
    Wang H; Lu X; Yang X; Ning Q
    Int J Clin Exp Med; 2015; 8(11):20111-22. PubMed ID: 26884924
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Attention-getting sexually transmitted diseases: Hepatitis B].
    Takahashi S; Chayama K
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2450-5. PubMed ID: 18069297
    [No Abstract]   [Full Text] [Related]  

  • 78. Trends in chronic hepatitis B treatment-related research from 1973 to 2018: a bibliometric and visual analysis.
    Li G; Lin J; Jiang C; Feng Q; Wen L
    J Int Med Res; 2020 Apr; 48(4):300060519893234. PubMed ID: 31878813
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Subjective literature review: adefovir-dipivoxil].
    Vilde JL
    Med Mal Infect; 2004 Apr; 34(4):180. PubMed ID: 15619890
    [No Abstract]   [Full Text] [Related]  

  • 80. Entecavir: a potent new antiviral drug for hepatitis B.
    Honkoop P; De Man RA
    Expert Opin Investig Drugs; 2003 Apr; 12(4):683-8. PubMed ID: 12665423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.